May 27, 2025
Apotex launches nilotinib capsules, the first generic version of Tasigna®(1) in the United States, with 180 days of exclusivity
May 20, 2025
Apotex publishes 2024 Sustainability Report, highlighting progress and achievements in environmentally sustainable manufacturing, responsible business practices, and social impact
May 09, 2025
Apotex introduces IVRA(TM) (Melphalan) hydrochloride injection: First ready to dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA in the United States
May 06, 2025
Apotex announces expansion of licensing agreement with Formosa Pharmaceuticals to Mexico for commercialization of clobetasol propionate ophthalmic suspension for the treatment of inflammation and pain following ocular surgery
Feb 24, 2025
Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal
Feb 13, 2025
Apotex announces grant to Healthy Mothers, Healthy Babies Coalition of Broward County to promote maternal health with $242,000 in annual funding
Jan 09, 2025
Apotex acquires US rights to PROVIGIL® (modafinil) and NUVIGIL® (armodafinil)
Sep 24, 2024
Apotex certified as a Great Place To Work in Canada, the U.S., and India
Jun 04, 2024
Apotex to Participate in the Jefferies Global Healthcare Conference 2024
Jun 03, 2024
Apotex Completes Acquisition of Searchlight, a leading Canadian-based Specialty Innovative Branded Pharmaceutical Company
Apr 16, 2024
Apotex Inc. to Present at the 2024 Bloom Burton & Co. Annual Healthcare Investor Conference
Apr 02, 2024
Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader
May 26, 2020
Apotex Corp. Donates Critical Medicines in the Fight Against COVID-19
Apr 21, 2020
Canada's Apotex Donates Two Million Dosages of Hydroxychloroquine to the Public Health Agency of Canada
Feb 05, 2020
Information Update - Apotex Inc. recalls certain lots of the diabetes medication APO-Metformin ER (extended release) 500 mg tablets
Dec 05, 2019
Apotex Releases New Supply of Tamoxifen Into Canadian Market
Mar 09, 2019
Information Update - Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
Feb 28, 2019
Patient access to cost-effective treatments increased with launch of new biosimilar in Canada
Oct 26, 2018
/R E P E A T -- Media Advisory: Press Conference - Sherman Family Investigative Team Provides Update on Double Homicide/
Oct 24, 2018
Media Advisory: Press Conference - Sherman Family Investigative Team Provides Update on Double Homicide